Search
Patexia Research
Case number 2021-1654

Daewoong Pharmaceutical Co., Ltd. v. ITC > Documents

Date Field Doc. No.Description (Pages)
Jul 26, 2021 10 ORDER filed granting motions [779168-2] [779190-2] to the extent that the appeals are deemed moot and the matter is remanded for the Commission to address vacatur of its final determination. Any pending motions [780550-2] are denied as moot. The parties shall bear their own costs.; issuing mandate. Service as of this date by the Clerk of Court. [788576] [21-1653, 21-1654] [LMS] [Entered: 07/26/2021 10:01 AM] (3)
Jun 30, 2021 9 ORDER granting [779148-3] [779189-2] the motions, ECF Nos. 60 and 63. The revised official caption and short caption are reflected above. The parties shall bear their own costs with respect to Evolus and Allergan. Service as of this date by the Clerk of Court. [783451] [21-1653, 21-1654] [LMS] [Entered: 06/30/2021 11:40 AM] (2)
Apr 16, 2021 8 ORDER filed granting motion [762879-2] to the extent that ECF Nos. [756018-2] and [757147-2] are withdrawn, the interim stay is lifted, and the briefing schedule is stayed. Medytox’s motion [763124-2] is granted. The revised official caption is reflected in the order. Within fourteen days of the Commission’s resolution of the petition to rescind the underlying remedial orders, the parties are directed to inform this court as to how they believe these appeals should proceed. Service as of this date by the Clerk of Court. [769356] [21-1653, 21-1654] [NL] [Entered: 04/16/2021 02:57 PM] (3)
Feb 17, 2021 5 Entry of appearance for Nicholas Groombridge; Kannon K. Shanmugam; Josephine Young as counsel for Appellant Evolus, Inc.. Service: 02/17/2021 by email. [756764] [21-1654] [Nicholas Groombridge] [Entered: 02/17/2021 12:31 PM] (0)
Feb 17, 2021 6 Entry of appearance for Thomas C. Goldstein; Charles H. Davis; Daniel Zaheer; Benjamin J.A. Sauter as counsel for Appellant Daewoong Pharmaceutical Co., Ltd.. Service: 02/17/2021 by email. [756794] [21-1654] [Thomas Goldstein] [Entered: 02/17/2021 01:45 PM] (0)
Feb 17, 2021 7 Note to File: The following cases are consolidated: 21-1653 Lead with 21-1654 Cross-Appeal. The parties must file all documents in the lead appeal only. [756857] [21-1653, 21-1654] [LMN] [Entered: 02/17/2021 03:12 PM] (0)
Feb 16, 2021 4 CORRECTED ORDER: correcting Court Order for response or reply [3]; reason(s): to correct the year in Action 6. Service as of this date by the Clerk of Court. [756085] [21-1653, 21-1654] [LMS] [Entered: 02/16/2021 08:41 AM] (0)
Feb 15, 2021 1 Appeal docketed. Received: 02/14/2021. [756068] Fee/IFP due on 03/02/2021. Entry of Appearance is due on 03/02/2021. Certificate of Interest is due on 03/02/2021. Docketing Statement is due on 03/18/2021. Certified List is due on 03/29/2021. [CAB] [Entered: 02/15/2021 04:17 PM] (0)
Feb 15, 2021 2 Filing fee paid. Fee Amount: $500.00. Receipt Number: A13-35254-811. [756072] [21-1654] [Thomas Goldstein] [Entered: 02/15/2021 04:49 PM] (0)
Feb 15, 2021 3 ORDER filed granting motion for leave to intervene [756015-2] in 21-1653 Daewoong Pharmaceutical Co., Ltd. and Evolus, Inc. added to the case.; Appeal Nos. 2021-1653 and 2021-1654 are consolidated in the nature of cross-appeals, and the motion for a stay and motion for interim relief shall be deemed to be filed in connection with both appeals. The revised official captions are reflected above. Allergan and Medytox's motion for leave to file out-of-time [756066-2] is granted. The motion for an interim stay [756017-2] is granted to the extent that the Remedial Orders are temporarily stayed and the government is directed not to enforce the Remedial Orders until further notice while the court considers the motion for a stay pending appeal. Any oppositions to the motion to stay [756018-2] are due no later than March 2, 2021. Any reply in support of the motion is due no later than March 5, 2021. (see order for details) (Per Curiam). Service as of this date by the Clerk of Court. [756075] [21-1653, 21-1654] --[Edited 02/16/2021 by LMS to change the year for the due dates] [LMS] [Entered: 02/15/2021 05:41 PM] (0)
Menu